Emergent BioSolutions (EBS) Interest & Investment Income (2011 - 2018)

Emergent BioSolutions' Interest & Investment Income history runs 8 years deep, the most recent figure standing at $701000.0 for Q3 2018.

• In Q3 2018, Interest & Investment Income rose 10.05% year-over-year to $701000.0; the TTM figure through Sep 2018 stood at $1.4 million (down 26.2% YoY), while the FY2017 annual figure was $1.8 million, up 66.48% from the prior year.
• Interest & Investment Income was $701000.0 for Q3 2018 at Emergent BioSolutions, up from $306000.0 in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $701000.0 in Q3 2018 to a low of $31000.0 in Q2 2014.
• Historically, Interest & Investment Income has averaged $259263.2 across 5 years, with a median of $219000.0 in 2016.
• The sharpest annual moves came in 2014 and 2018: Interest & Investment Income surged 955.56% in 2014, then tumbled 47.51% in 2018.
• A 5-year view of Interest & Investment Income shows it stood at $190000.0 in 2014, then plunged by 40.53% to $113000.0 in 2015, then jumped by 155.75% to $289000.0 in 2016, then sank by 44.64% to $160000.0 in 2017, then soared by 338.12% to $701000.0 in 2018.
• The last three Interest & Investment Income figures came in at $701000.0 (Q3 2018), $306000.0 (Q2 2018), and $222000.0 (Q1 2018), per Business Quant data.